Talphera (TLPH) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

) has been revised to $3.32 / share. This is a decrease of 22.00% from the prior estimate of $4.25 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...

As of May 2, 2024, the average one-year price target for Talphera is 5.23. The forecasts range from a low of 4.29 to a high of $6.30. The average price target represents an increase of 412.50% from ...

Talphera Inc (NASDAQ:TLPH) successfully completed the first closing of a $17 million two-tranche financing, providing sufficient capital for planned approval of the NAIAD PMA. Strategic investment ...

Welcome to the Talphera First Quarter 2025 Financial Results Conference Call. This call is being webcast live via the Events page of the Investors section of Talphera's website at www.talphera.com.

The average one-year price target for Talphera (NasdaqGM:TLPH) has been revised to 5.23 / share. This is an increase of 10.81% from the prior estimate of 4.72 dated January 16, 2024. The price target ...

Management shifted its projected completion timelines for the nephro study to 2026 due to slow activation at four high-volume academic sites. The company secured $17 million in fresh financing and ...